BotoxClass.com
References
Botox for Bruxism
Ågren, Martin, Christofer Sahin, and Mattias Pettersson. “The Effect of Botulinum Toxin Injections on Bruxism: A Systematic Review.” Journal of Oral Rehabilitation 47, no. 3 (2020): 395–402. https://doi.org/10.1111/joor.12914.
Fernández-Núñez, T., S. Amghar-Maach, and C. Gay-Escoda. “Efficacy of Botulinum Toxin in the Treatment of Bruxism: Systematic Review.” Medicina Oral, Patologia Oral Y Cirugia Bucal 24, no. 4 (July 1, 2019): e416–24. https://doi.org/10.4317/medoral.22923.
Botox for Depression
Khademi, Mohammad, Masoumeh Roohaninasab, Azadeh Goodarzi, Farnoosh Seirafianpour, Milad Dodangeh, and Arash Khademi. “The Healing Effects of Facial BOTOX Injection on Symptoms of Depression alongside Its Effects on Beauty Preservation.” Journal of Cosmetic Dermatology 20, no. 5 (2021): 1411–15. https://doi.org/10.1111/jocd.13990.
Wollmer, M. Axel, Michelle Magid, Tillmann H. C. Kruger, and Eric Finzi. “The Use of Botulinum Toxin for Treatment of Depression.” In Botulinum Toxin Therapy, edited by Scott M. Whitcup and Mark Hallett, 263:265–78. Handbook of Experimental Pharmacology. Cham: Springer International Publishing, 2019. https://doi.org/10.1007/164_2019_272.
Zamanian, Abbas, Atefeh GHANBARI Jolfaei, and Golnaz Mehran. “Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression,” n.d., 3.
Zhang, Qilin, Wenqi Wu, Yuxin Fan, Yang Li, Jing Liu, Yingying Xu, Caixia Jiang, et al. “The Safety and Efficacy of Botulinum Toxin A on the Treatment of Depression.” Brain and Behavior 11, no. 9 (2021): e2333. https://doi.org/10.1002/brb3.2333.
Botox for Migraine
Chan, Tommy Lik Hang. “OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.” Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques 49, no. 4 (July 2022): 477–78. https://doi.org/10.1017/cjn.2021.159.
Zandieh, Ali, and Fred Michael Cutrer. “OnabotulinumtoxinA in Chronic Migraine: Is the Response Dose Dependent?” BMC Neurology 22, no. 1 (December 2022): 218. https://doi.org/10.1186/s12883-022-02742-x.
Botox for Stress Headache
Argyriou, Andreas A., Dimos-Dimitrios Mitsikostas, Elisa Mantovani, Michail Vikelis, and Stefano Tamburin. “Beyond Chronic Migraine: A Systematic Review and Expert Opinion on the off-Label Use of Botulinum Neurotoxin Type-A in Other Primary Headache Disorders.” Expert Review of Neurotherapeutics 21, no. 8 (August 3, 2021): 923–44. https://doi.org/10.1080/14737175.2021.1958677.
Freund, Brin, and Aruna Rao. “Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.” Pain Practice 19, no. 5 (2019): 541–51. https://doi.org/10.1111/papr.12773.
Gfrerer, Lisa, Wenjie Xu, William Austen, Sait Ashina, Agustin Melo-Carrillo, Maria Serena Longhi, Aubrey Manack Adams, Timothy Houle, Mitchell F Brin, and Rami Burstein. “OnabotulinumtoxinA Alters Inflammatory Gene Expression and Immune Cells in Chronic Headache Patients.” Brain, December 21, 2021, awab461. https://doi.org/10.1093/brain/awab461.
Roland, Sissel Breivold, Are Hugo Pripp, Mbachi Ruth Msomphora, and Gunnvald Kvarstein. “The Efficacy of Botulinum Toxin A Treatment for Tension-Type or Cervicogenic Headache: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials.” Scandinavian Journal of Pain 21, no. 4 (October 26, 2021): 635–52. https://doi.org/10.1515/sjpain-2021-0038.
Schulte-Mattler, W. J., and J. C. Martinez-Castrillo. “Botulinum Toxin Therapy of Migraine and Tension-Type Headache: Comparing Different Botulinum Toxin Preparations.” European Journal of Neurology 13, no. s1 (2006): 51–54. https://doi.org/10.1111/j.1468-1331.2006.01445.x.